N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine
C17H15F4N5O — CID 163441994
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine
N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine (PubChem CID 163441994) has the molecular formula C17H15F4N5O and a molecular weight of 381.33 g/mol. Its IUPAC name is N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine.
Molecular Properties
| Compound Name | N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine |
|---|---|
| PubChem CID | 163441994 |
| Molecular Formula | C17H15F4N5O |
| Molecular Weight | 381.33 g/mol |
| Exact Mass | 381.12 |
| IUPAC Name | N-[(3S,4S)-4-fluoropyrrolidin-3-yl]-6-[7-(trifluoromethoxy)imidazo[1,2-a]pyridin-3-yl]pyridin-2-amine |
| SMILES | F[C@H]1CNC[C@@H]1Nc1cccc(-c2cnc3cc(OC(F)(F)F)ccn23)n1 |
| InChI | InChI=1S/C17H15F4N5O/c18-11-7-22-8-13(11)25-15-3-1-2-12(24-15)14-9-23-16-6-10(4-5-26(14)16)27-17(19,20)21/h1-6,9,11,13,22H,7-8H2,(H,24,25)/t11-,13-/m0/s1 |
| InChIKey | AZIKDQBYCZVPSU-AAEUAGOBSA-N |
| XLogP | 3.02 |
| TPSA | 63.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 381.33 |
| LogP ≤ 5 | 3.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163441994 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.